Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia

被引：0
|
作者：
Diebold, Kendall [1 ]
Worth, Sarah [2 ]
Bachiashvili, Kimo [2 ]
Vachhani, Pankit [3 ]
Rangaraju, Sravanti [1 ]
Espinoza-Gutarra, Manuel [1 ]
Al-Kadhimi, Zaid [1 ]
Bhatia, Ravi [1 ]
Jamy, Omer [4 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[3] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Div Hematol Oncol, Birmingham, AL USA
[4] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib
    Alexander E. Perl
    Naoko Hosono
    Pau Montesinos
    Nikolai Podoltsev
    Giovanni Martinelli
    Nicki Panoskaltsis
    Christian Recher
    Catherine C. Smith
    Mark J. Levis
    Stephen Strickland
    Christoph Röllig
    Marco Groß-Langenhoff
    Wen-Chien Chou
    Je-Hwan Lee
    Hisayuki Yokoyama
    Nahla Hasabou
    Qiaoyang Lu
    Ramon V. Tiu
    Jessica K. Altman
    Blood Cancer Journal, 12
  • [42] Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients - Czech center experience
    Weinbergerova, Barbora
    Cernan, Martin
    Kabut, Tomas
    Semerad, Lukas
    Podstavkova, Natalia
    Szotkowski, Tomas
    Jeziskova, Ivana
    Mayer, Jiri
    HAEMATOLOGICA, 2023, 108 (10) : 2826 - 2829
  • [43] Phase II Study of Midostaurin plus Chemotherapy in Pediatric Patients with Untreated, Newly Diagnosed, FLT3-Mutated Acute Myeloid Leukemia (AML)
    Reinhardt, Dirk
    Zwaan, Christian Michel
    Hoenekopp, Albert
    Niolat, Julie
    Ifrah, Sophie
    Noel-Baron, Florence
    Locatelli, Franco
    BLOOD, 2019, 134
  • [44] Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia
    Lap, Coen J.
    Abrahim, Marwa S. H.
    Nassereddine, Samah
    ANNALS OF HEMATOLOGY, 2024, 103 (07) : 2215 - 2229
  • [45] Evaluation of the Toxicity and Outcomes of the Combination of Midostaurin and CLAG-M in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML): A Multicenter Retrospective Analysis
    Chen, Ashley
    Baek, Grace
    Russell, Kathryn
    Shaw, Carole
    Othus, Megan
    Cohen, Jonathan
    Palmer, Shannon
    Rasmussen, Jack
    Bubalo, Joseph
    Tsomo, Tenzin
    Schwarz, Tenley
    Namburi, Swathi
    Halpern, Anna
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [46] A Phase I Study to Evaluate the Safety and Tolerability of Gemtuzumab Ozogamicin and Midostaurin When Used in Combination with Standard Cytarabine and Daunorubicin Induction for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia
    Borate, Uma
    Dvorak-Kornaus, Kaitlyn M.
    Zhao, Qiuhong
    Walter, Roland B.
    Cook, Rachel J.
    Saultz, Jennifer N.
    Swords, Ronan T.
    Grieselhuber, Nicole R.
    Mims, Alice
    Larkin, Karilyn T.
    Sahasrabudhe, Kieran D.
    Blachly, James S.
    Behbehani, Gregory K.
    Eisfeld, Ann-Kathrin
    Long, Meixiao
    Srisuwananukorn, Andrew
    Koenig, Kristin L.
    BLOOD, 2024, 144 : 4286 - 4287
  • [47] A SYSTEMATIC REVIEW OF THE HUMANISTIC BURDEN OF FLT3-MUTATED RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
    Casamayor, M.
    Gubbels, L.
    Garnham, A.
    Shah, M., V
    VALUE IN HEALTH, 2020, 23 : S29 - S29
  • [48] ESTIMATION OF HEALTH STATE UTILITIES IN FLT3-MUTATED RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
    Cella, D.
    Qi, C. Z.
    Yang, H.
    Garnham, A.
    Shah, M., V
    VALUE IN HEALTH, 2020, 23 : S77 - S78
  • [49] Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
    Sierra, Jorge
    Montesinos, Pau
    Thomas, Xavier
    Griskevicius, Laimonas
    Cluzeau, Thomas
    Caillot, Denis
    Legrand, Ollivier
    Minotti, Clara
    Luppi, Mario
    Farkas, Firas
    Bengoudifa, Bourras-Rezki
    Gilotti, Geralyn
    Hodzic, Sejla
    Rambaldi, Alessandro
    Venditti, Adriano
    BLOOD ADVANCES, 2023, 7 (21) : 6441 - 6450
  • [50] RADIUS-X: An Expanded Treatment Protocol for Midostaurin in Combination with Standard Chemotherapy in Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia
    Roboz, Gail
    Strickland, Stephen
    Litzow, Mark
    Dalovisio, Andrew
    Perl, Alexander
    Bonifacio, Gaetano
    Haines, Kelly
    Barbera, Alysha
    Purkayastha, Das
    Sweet, Kendra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S202 - S203
12345